TINAVI(688277)2025-01-24 10:15Revenue Expectations - The company expects 2024 revenue to be between 160 million and 192 million CNY, a decrease of 8.59% to 23.82% compared to the previous year[2]. - In the previous year (2023), the company reported revenue of 210 million CNY and a net loss of 156 million CNY[3]. Net Loss Projections - The net loss attributable to the parent company is projected to be between 104 million and 130 million CNY, narrowing the loss by 16.87% to 33.50% compared to the previous year[2]. - The net loss attributable to the parent company after deducting non-recurring gains and losses is expected to be between 144 million and 180 million CNY, with a reduction of 15.89% to 32.71% compared to the previous year[2]. Factors Affecting Performance - The decline in revenue is attributed to macroeconomic pressures and increasing industry competition[4]. - The company has optimized cost control, leading to a reduction in net loss compared to the previous year[5]. Surgical Robot Performance - The Tianji orthopedic surgical robot performed over 39,000 surgeries during the reporting period, with a cumulative total exceeding 100,000 surgeries[7].